Symbols

DXCM

Dexcom·NASDAQ

--(--)

Market Open: --

--(--)

Pre-Market: --

Signals Analysis

Bullish signal 6

Bearish signal 0

Consensus Rating "Strong Buy"

Ample Liquidity

High Gross Profit Margin

High Cash/net Profit Ratio

Revenue Beats Expectation

EPS Beats Expectation

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About DXCM

Dexcom, Inc.

A leader of diabetes care technology

Industry

Healthcare Equipment and Supplies

Established Date

Listing Date

04/14/2005

Exchange

NASDAQ Stock Exchange

Full-time Employees

10,200

Fiscal Year Ends

12-31

Website

www.dexcom.com

Security Type

Common stock

Office address

6340 Sequence Drive, San Diego, CA 92121

Business

Introduction

Dexcom, Inc. is a company incorporated in Delaware. The Company is a medical device company focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes in patients, caregivers and clinicians around the world.

Earnings Call

Q2/2025

Estimate EPS0.45

Actual EPS0.48

Estimate Revenue1.12B

Actual Revenue1.16B

Contradictions Unveiled: Key Takeaways from the Latest Earnings Call on U.S. Growth, User Retention, and Revenue Guidance

Aug 03,2025 02:41·
Earnings Decrypt

Q3/2025

Estimate EPS0.57

Actual EPS0.61

Estimate Revenue1.18B

Actual Revenue1.21B

DexCom's Q3 2025: Contradictions Emerge on New Start Retrieval, Pricing Trends, and Sensor Launch Delays

Oct 30,2025 10:25·
Earnings Decrypt

Company Financials

EPS

DXCM has released its 2025 Q3 earnings. EPS was reported at 0.61, versus the expected 0.57, beating expectations. The chart below visualizes how DXCM has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

DXCM has released its 2025 Q3 earnings report, with revenue of 1.21B, reflecting a YoY change of 21.64%, and net profit of 283.80M, showing a YoY change of 110.85%. The Sankey diagram below clearly presents DXCM's revenue sources and cost distribution.